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ABSTRACT  
Background: Organophosphate poisoning is still a major problem in developing countries 
owing to indiscriminate use of these compounds in many households. The risk of poisoning 
is worsened by uncontrolled sale of organophosphorus insecticides on the streets and in open 
markets. We report three cases of organophosphate compound poisoning among adolescents 
with suicidal intent.  
Methods: We reviewed the hospital admission case records of three cases of 
organophosphate poisoning among adolescents managed at the children emergency room of 
University of Nigeria Teaching Hospital, Ituku Ozalla, Enugu, South-east Nigeria. Relevant 
information on the clinical characteristics of the patients, investigations and treatment, and 
outcome of treatment were obtained. 
Results: The events of poisoning were preceded by strained family relationship in two of the 
cases while failure in a promotional examination preceded the incident in one of them. 
Atropine monotherapy in addition to airway management and oxygen support successfully 
reversed the symptoms and signs in 2 of the 3 cases. One died within 18 hours of admission 
from cardio-respiratory depression. Mean duration of admission in patients that survived 
was 48 hours.  
Conclusion: This report highlights the ugly trend of suicidal ideation among adolescents and 
the challenges of management of organophosphate poisoning in our setting. It serves as a 
wake-up call to Nigerian parents and healthcare providers on the increased risk of 
indiscriminate use of organophosphorus compounds as insecticides in the homes.   
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Organophosphate compounds are a diverse 
group of chemicals used in both domestic and 
industrial settings, examples of which include 
insecticides, nerve gases and antihelminthics.1 
These chemicals kill insects and cause 
poisoning in animals by inhibiting the 
enzyme, acetylcholinesterase (AChE) which 
degrades acetylcholine in nerve synapses. 
Inhibition of AChE in the nerves results in a 
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buildup of acetylcholine (ACh) and 
overstimulation of ACh receptors.2  Death 
from acute poisonings is frequently due to 
respiratory failure resulting from inhibition of 
central (medullary) respiratory drive, 
excessive bronchial secretions, and 
bronchospasms coupled with depolarizing 
blockade at neuromuscular junctions 
(diaphragm and inter-costals).2 Over a 
hundred organophosphate compounds 
representing a variety of chemical, physical 
and biological properties are in commercial 
use.3   Organophosphate insecticides are 
common household products in Nigeria, 
where they are used mainly to control 
mosquitoes and other household pests such as 
cockroaches and bed bugs. More than 80% of 
the reported toxic exposures to insecticides are 
attributable to organophosphates.4  
The most popular source of organophosphate 
insecticide/pesticide in Nigeria is the locally 
made variety called ‘Otapiapia’.5   The main 
active ingredient in ‘otapiapia’ is dichlorvos or 
2, 2-dichlorovinyl dimethyl phosphate 
(DDVP), with most containing between 5-10% 
w/v6 and are readily available for purchase on 
the streets. ‘Sniper’, which is another common 
variety of DDVP has a more refined packaging 
and is available in stores nationwide at a 
higher cost. Organophosphate poisoning may 
occur through ingestion, inhalation or 
penetration through the intact skin; and may 
be suicidal, accidental or homicidal. Most of 
the cases are accidental.7, 8 The World Health 
Organization (WHO) noted that pesticide 
poisoning is now the most common method of 
suicide worldwide.9, 10 About two million 
people attempt suicide and one million 
accidental poisoning cases occur each year 
worldwide.4 Suicide accounts for an estimated 
849,000 deaths worldwide,9 and ~ 300,000 
deaths in the developing world every year.11  
In Nigeria, suicide is traditionally a taboo. 
However, the recent report of cases of 
intentional poisoning is probably as a result of 
media influence or breakdown of our 
traditional social fabric. A ten-year 
retrospective study of childhood poisoning in 
Warri, South-south Nigeria, noted that 
intentional poisoning occurred in the 
adolescent age group and mainly involved 
female teenagers.8  Shwe et al12 observed that 
organophosphates were the sole agent for 
intentional poisoning in the retrospective 
review of cases seen in North-central Nigeria 
and these were adolescent females. We report 
three cases of adolescent organophosphates 
poisoning with suicidal intent in our setting 
and also the challenges of managing such 
cases in resource poor settings. 
CASE REPORT 
Case 1: UA was a 15 years old female who 
first presented at Enugu State University 
Teaching Hospital, (ESUTH) with history of 
abdominal pain, salivation, loss of 
consciousness and urinary incontinence 
about 30 minutes after ingestion of an 
organophosphate insecticide/pesticide, 
“sniper”. Ingestion followed failure in her 
college promotional examination. 
Candidates that fail this promotional 
examination are usually demoted to a lower 
class.  Her academic performance was said to 
be average in her previous levels. She was 
the first child in a monogamous family with 
4 children and there was no history 
suggestive of a strained relationship with her 
family or peers.  At presentation, she was 
unconscious with Glasgow Coma Score (GCS) 
of 3/15, drooling saliva, in respiratory distress, 
tachypneoic and febrile (37.80C).  Both pupils 
were pin point and there were widespread 
crepitations on all lung zones. Pulse was 120 
beats/minute and blood pressure was 100/60 
mmHg. Oxygen saturation (SpO2) by pulse 
oximetry was 64% on room air and Random 
blood Glucose (RBG) was 6.3mmol/litre.  
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The airway was cleared and intranasal oxygen 
commenced. Intravenous atropine 2.5mg was 
administered every 15 minutes and pupils 
became normal sized after the third dose. The 
level of consciousness improved and she was 
transferred to the Intensive Care Unit (ICU) of 
the University of Nigeria Teaching Hospital 
(UNTH), Ituku/Ozalla, Enugu, which was a 
distance of about 25km, for respiratory 
support.  On arrival at the ICU, GCS was 10/15 
(E-3, M-6, V-1), pupils were constricted (pin 
point) and she was in severe respiratory 
distress; SpO2 was 71% on room air and 
respiratory rate was 20 breaths/minute. There 
were widespread coarse crepitations, 
prolonged capillary refill time, cold 
extremities, small volume pulse with a rate of 
80 beats/minute, and a blood pressure of 
90/40 mmHg; RBG was 3.3mmol/litre. She 
was restarted on hourly doses of atropine.  
Pralidoxime was not administered due to 
unavailability of the drug. Intravenous 
boluses of normal saline were given. 
Subsequently, intravenous dopamine and 
epinephrine were commenced to maintain 
systemic circulation. She also received 5% 
dextrose saline to maintain euglycaemia.  She 
regained full consciousness about 12 hours 
later. Blood pressure normalized and SaO2 
remained between 96% and 99% on 100% 
oxygen; she was then extubated after 12 hours 
on mechanical ventilator. Following 
extubation, her condition deteriorated rapidly 
with loss of consciousness and rapid drop in 
oxygen saturation.  Attempt at resuscitation 
failed.  
Case 2: KA was a 15 years old adolescent 
female who presented to UNTH with history 
of excessive vomiting and increased 
sweating following ingestion of ‘otapiapia’- 
a locally made organophosphate14 hours 
prior to presentation. Patient’s mother was 
said to have unjustly accused her of having 
unhealthy relationships with some 
adolescent males within their 
neighbourhood. Following the rancour, she 
locked herself in a room and attempted 
suicide by ingesting the ‘otapiapia’.  
Estimated volume of the ingested substance 
was about 10mls. A few minutes later, she 
started frothing from the mouth, 
necessitating her calling for help. An attempt 
to reverse the effects of the poison with some 
local remedies such as palm oil and coconut 
water believed to be antidote to poisons for a 
period of 2 hours yielded no results. She was 
subsequently taken to a nearby hospital 
(ESUTH).  She vomited twice on the way to 
the health facility. While on admission at the 
hospital she also developed fever, cough, fast 
and difficult breathing, and chest pain. She 
received intravenous fluids and 
intramuscular injections and was 
subsequently referred to UNTH for further 
evaluation and treatment.   
Patient is the first child of her family and a 
senior secondary 2 student in a government 
school, whose academic performance has 
been good; she belonged to the low 
socioeconomic class.  There is no antecedent 
history suggestive of psychosocial instability 
prior to this incident.                                                            
Salient findings on presentation were a 
conscious adolescent female with pyrexia, 
mild pallor, respiratory distress, and bi-basal 
coarse crepitations. Initial vital signs were as 
follows: temperature of 38oC, respiratory rate 
of 44 breaths per minute, oxygen saturation on 
room air (SpO2) of 95%, capillary refill time 
was < 2 seconds, pulse rate was 120 
beats/minute and blood pressure of 120/70 
mmHg. Random blood glucose was 
5.8mmol/L and Haematcrit 29%.  Dipstick 
urinalysis showed: specific gravity 1.030, 
blood: 3+, leukocyte: 2+, protein: +, ketone: +.  
Serum electrolyte, urea, creatinine was 
essentially normal. She was commenced on 
intranasal oxygen, intravenous infusion, stat 
dose of intravenous atropine 2.5mg and 
intravenous ceftriaxone 2g daily.  Urine output 
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and vital signs remained normal with close 
monitoring. Subsequently, oxygen saturation 
fluctuated between 82% and 92% on intranasal 
oxygen but improved to between 95% and 99% 
with periodic airway suction. She stabilized 
within 72 hours with complete resolution of 
symptoms and signs. She was counselled and 
discharged home to continue follow up at the 
adolescent and psychological medicine clinics. 
Case 3: EK was a 13 year old male who 
presented to our facility with a history of 
vomiting, and excessive sweating following 
ingestion of about 3mls of organophosphate 
insecticide/pesticide (otapiapia) an hour 
prior to presentation. There was no 
lacrimation or wheezing.  
He was accused of stealing his mother’s cell 
phone on instruction by his peers. On 
account of this act, he had a dispute with his 
parents and he then ingested the 
organophosphate compound with suicidal 
intent. Prior to presentation, he had received 
about 20ml of palm oil as home-made 
remedy. Patient is the last child in a 
monogamous family with 5 children and a 
junior secondary 2 student with good 
academic performance; he belonged to the 
upper socioeconomic class. There was no 
antecedent behavioural abnormality prior to 
this incidence. 
Findings on presentation were an anxious 
adolescent male, diaphoretic, with strong 
stench of organophosphate perceived from his 
body. Pupillary examination showed bilateral 
miosis. Cardiopulmonary examination and 
vital signs showed tachypnoea but no 
dyspnoea. Respiratory rate was 40 
breaths/minute; pulse rate - 82 beats/min., 
blood pressure - 110/ 60 mmHg and 
temperature - 36oC. There was no adventitia 
on the lung fields. The general and 
neurological examinations were normal. No 
other significant findings. Laboratory 
investigation including a complete blood 
count, urea and electrolytes were normal. 
Lactic acid levels and arterial blood gasses 
were not checked. Plasma 
pseudocholinesterase and red cell 
cholinesterase levels could not be assayed. 
Emergency resuscitative measures included 
gastric lavage with normal saline; 
maintenance intravenous 5% dextrose saline 
infusion. Urine output remained essentially 
normal. He also received intravenous atropine 
at 0.05mg/kg/dose, ~ 2mg stat, repeated after 
15 minutes. On subsequent review an hour 
later, symptoms had reversed. Vomiting had 
subsided, no diaphoresis; pupils were normal 
size reacting normally to light. Twenty four 
hours into admission, patient was alert; vital 
signs had normalized (temperature 36oC, 
respiratory rate 20 breaths/minute, pulse rate 
80 beats/ minute).  No abnormal findings on 
systemic examination. He was discharged 
after 24 hours of admission. He was counselled 
and subsequently referred to adolescent and 
psychological medicine clinics for review.  
DISCUSSION 
Organophosphate (OP) poisoning is not 
uncommon, and may result in death because 
of its high toxicity.13   Adolescents usually 
attempt suicide following emotional trauma 
from family stress or failed relationships with 
the opposite sex. Organophosphate 
insecticide/pesticide seems to be the 
commonest agent because it is readily 
available and easily accessible to users despite 
its marked toxicity.  The reported cases 
buttress this fact. Some of the documented 
factors contributing to fatal poisonings are 
availability, low price, inappropriate use and 
storage of pesticides; unsafe disposal or reuse 
of pesticide containers as well as lack of 
adequate regulations controlling their sale.14, 15 
The ease of access to these hazardous products 
resulted in serious health threats as observed 
in these patients. Nigeria has no strict 
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regulations/guidelines on importation and 
sales of these hazardous products to the 
general public. Similarly, many African 
countries do not have well established poison 
control centres.16   ‘Sniper’, one of the poisoning 
agents in this series, belonging to the 
dichlorvos or 2,2-dichlorovinyl dimethyl 
phosphate compound (DDVP) chemical 
family is very popular in Nigeria and readily 
available in Nigerian markets and shops.  It is 
meant for agricultural and industrial use and 
never for indoor use.  However, many 
Nigerian families use it as insecticide/ 
rodenticide in their homes.  
Organophosphates is the sole agent for 
intentional poisoning in adolescents8, 12 
especially in females. Intentional poisoning in 
adolescents are precipitated by psychosocial 
factors such as family stress, trauma from a 
failed relationship8 and sometimes failure in 
examinations as was obtainable in one of the 
cases highlighted. The events of poisoning 
were preceded by strained family relationship 
in two of the cases while failure in a 
promotional examination preceded the 
incident in one of them. All organophosphate 
preparations are absorbed through the 
bronchi, intact skin, mucous membrane and 
conjunctiva as well as through the 
gastrointestinal tract.17-20 These patients were 
exposed to the toxic agents through the 
gastrointestinal route.  Toxic effects of the 
different compounds vary considerably 
depending on age; route and duration of 
exposure; and inherent characteristics 
(lipophilicity) of the specified chemical 
justifying the identification of the agent 
involved as soon as possible.  
Organophosphates inhibit the cholinesterase 
activity thereby prolonging and intensifying 
the effects of acetylcholine.17-20 Acetylcholine 
(ACH), a neurotransmitter binds with 
nicotinic and muscarinic receptors to trigger 
off action potential.  It is inactivated by 
Cholinesterase via hydrolysis. Organophosphates 
bind to and inactivate Cholinesterases (acetyl 
cholinesterase), and allows ACH to 
accumulate at the synapse leading to 
overstimulation. Cholinesterases are found in 
the red blood cell (true cholinesterase) and 
plasma (pseudo cholinesterase). Symptoms of 
exposure which typically appear within 30 to 
90 minutes after exposures18 are due to the 
continuous stimulation of the muscarinic and 
nicotinic receptors.   Muscarinic symptoms 
include excessive secretion from mucus 
membranes, increased pulmonary and 
oropharnygeal secretions, pupillary 
constriction manifesting as diarrhoea, 
excessive urination, miosis, bronchorrhea, 
bradycardia, emesis, lacrimation and 
salivation,13, 17, 18  commonly tagged with the 
mnemonic ‘DUMBBELS’. Adrenal medulla 
activity manifest as increased sweating and 
garlic smell because of vicarious excretion, 
bradycardia, abdominal cramping and 
intestinal hypermotility. Nicotinic activity 
results in autonomic nervous system 
stimulation manifesting as tachycardia, 
hypertension, sweating and rarely dilated 
pupil. Nicotinic overstimulation at the 
neuromuscular junction causes muscle 
weakness, fasciculation, fatigue and 
paralysis.13, 17, 18 With irreversible binding of 
organophosphate compound and 
cholinesterase (aging), symptoms are 
continuously manifested. These 
manifestations are graded into mild, moderate 
and severe based on the World Health 
Organization classification of severity of 
organophosphate poisoning.21 Based on this 
classification, two of the cases manifested 
features of moderate OP poisoning while the 
third had severe OP.  
Diagnosis of OP poisoning is made both 
clinically and with biochemical indicators. 
History of exposure to a known OP is 
important. Consistent with other reports19, 21, 
the most common clinical findings include 
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increased sweating, vomiting, respiratory 
distress, tachycardia, and miosis.  Miosis  is 
considered to be a very strong indicator of 
organophosphate poisoning.22 Red cell 
cholinesterase level is thought to be a good 
marker of synaptic function and atropine 
needs; and by extrapolation a good marker for 
severity.23   Clinical features of OP poisoning 
appear when RBC cholinesterase activity is 
<75% of normal and in clinically overt 
poisoning it is <10%.22   Chest X-ray may show 
evidence of pulmonary edema; and 
electrocardiography may show evidence of 
cardiac arrhythmia, QT prolongation, ST and 
T wave abnormalities in patients with 
abnormal heart rate and persistent 
hypotension.  Leucocytosis with or without 
neutrophilia may be present.  Brain 
computerized tomography scan may be 
required in cases with altered mental status. 
Diagnoses in these patients were promptly 
made based on clinical findings and a few 
laboratory findings, but confirmation by 
estimation of red cell or plasma 
pseudocholinesterase activity was not done 
due to lack of laboratory facilities.   
Following the key principles of management 
of OP poisoning18, 24   airway/ventilation 
support were provided for these patients.  
Intermittent suctioning of oral secretions and 
oxygen therapy formed part of the initial 
management in our patients. Mechanical 
ventilator support was provided in the 
intensive care for the patient with 
cardiopulmonary compromise. The duration 
for which organophosphates remain in the 
stomach after ingestion is still unknown.  
However, it is known that organophosphates 
are easily absorbed through mucus 
membranes within minutes of ingestion and 
gastric lavage is likely to play a role at the early 
stage of poisoning.24, 25 Guidelines for 
treatment of drug self-poisoning suggests that 
lavage should be considered only if the patient 
arrives within 1 hour of poison ingestion but 
there is no evidence that any form of gastric 
decontamination is of benefit to patients 
poisoned with organophosphorus.26   
Although gastric decontamination (irrigation 
with normal saline through a naso-gastric 
tube) was done in our patients.  Activated 
charcoal has not demonstrated sufficient 
evidence that it reduces morbidity and 
mortality in poisoned patients.27   Furthermore, 
late presentation makes any benefit doubtful. 
In our environment, victims of poisoning 
usually present late owing to the delays 
encountered while parents and sympathizers 
applying various ‘first aid treatment’28 (which 
are of no benefit) ranging from induction of 
emesis to use of palm oil, coconut water and so 
on, aimed at diluting the poisoning agent. 
Some of these were observed in the index 
cases.   
Atropine seems to be the mainstay of 
management of OP as it reverses the 
muscarinic effects.11, 22, 24, 29 Atropine is used for 
24 hours while OP is being degraded.  Using 
the intermittent bolus regimen30, it is 
recommended that large doses of atropine be 
given at a dose of 0.03-0.05mg/kg. This should 
be given intravenously every 10-20 minutes or 
‘pro re nata’,  then every 1-4 hourly for at least 
24 hours till signs of atropinisation (warm dry 
flushed skin, dilated pupil, increased 
HR>80b/min, systolic BP >80mmHg, and 
rapid reversal of bronchospasm and 
bronchorrhoea.24, 31) appear.  Patient UA, with 
severe symptoms had delay in time to 
atropinisation and deteriorated rapidly while 
the other two had remarkable response and 
were subsequently discharged following full 
recovery. It has been documented that delay in 
atropinisation can result in death from central 
respiratory depression, hypoxia (due to 
bronchospasm and bronchorrhoea) and 
hypotension (due to bradycardia and 
myocardial depression).32 Persisting 
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circulatory insufficiency may call for 
treatment with catecholamines to increase and 
maintain blood pressure as well as heart rate.33  
Atropine has no effect on nicotinic symptoms. 
In some cases, oximes like pralidoxime (2-
PAM), obidoxime, or asoximeis started as soon 
as the diagnosis is confirmed may help 
optimize outcome.23 Oximes are cholinesterase 
re-activators used as adjuncts to atropine in 
the treatment of organophosphate poisoning. 
They act primarily by reactivating the 
cholinesterase enzyme to restore the 
enzymatic destruction of acetylcholine at the 
neuromuscular junction and relieve muscle 
paralysis including respiratory muscles as 
well as reverse the nicotinic effect of the 
poison.24, 34   The benefits of oximes can be 
limited by high concentration of 
organophosphate in the blood, usually after 
ingestion of a large dose. Pralidoxime, unlike 
atropine does not cross the blood brain barrier 
and becomes useless when aging has already 
occurred.34 They are also ineffective if the 
patient presents after an hour of ingestion or 
develops severe complications like aspiration 
pneumonia or hypoxic brain injury before 
treatment.22, 24 Unfortunately,  dimethyl 
organophosphates such as 2,2-dichlorovinyl 
dimethyl phosphate compound, which is the 
active content in ‘sniper’ do not readily 
respond to the oximes unlike diethyl 
formulations-parathion and diazinon.35-38    
This is due to the fact that diethyl compounds 
reactivate and ‘age’ at a significantly slower 
rate than dimethyl compounds.36  The harmful 
effect of pralidoxime is another source of 
concern34, 36, 37, 38    
Early enteral feeding is recommended in stable 
patients as it is said to reduce entero-hepatic 
circulation and further absorption of the 
poison. Two of the patients were commenced 
on oral feeds as soon as they were stabilized. 
The third remained unstable on mechanical 
ventilation thus calories were maintained by 
intravenous infusion. Overall mortality in 
organophosphate poisoning is about 50% for 
those with severe toxicity.20 Mortality is 
mainly from respiratory failure.20, 39 The cause 
of death in our patient was attributable to 
severe poisoning, and early withdrawal of 
ventilator support resulting in respiratory 
failure and death.  Half of those with 
intentional poisoning in the study by Ugwu 
and colleagues8 died largely as a result of late 
presentation while 8 out of 117 patients seen 
by Syed et al38 with OP poisoning were dead 
on arrival.  Mechanical ventilation is required 
especially in patients with severe poisoning at 
risk of death from respiratory failure. Syed et 
al38 noted that mortality among those that were 
on mechanical ventilation for 2-7 days was 
7.2%, mechanical ventilation for more than 
seven days resulted in 33.3% mortality while 
mechanical ventilation for < 2 days resulted in 
100% mortality.  
Conclusion 
These cases highlight the tendency for 
poisoning with suicidal intent among 
adolescents in the study area environment and 
the need for anticipation of potential life 
threatening complications of organophosphate 
poisoning during treatment. Parents should be 
aware of the high risk of psychological 
imbalance among adolescents and endeavour 
to develop and maintain intimate relationship 
with their children in order to detect the early 
warning signs of emotional distrust in them.  
Increased awareness of this ugly trend will 
lead to early recognition of warning signs and 
thus prevent unnecessary loss of life.  Parents 
and caregivers should learn to store these 
poisonous agents in locked, hard to access 
cabinets. There is an urgent need to establish 
poison  control  and  information centres in 
each of the six geopolitical  regions  of  Nigeria,  
and  a  national  centre  in  Abuja, the Federal 
Capital Territory. Each centre should be 
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tagged with easy-to-recall telephone numbers 
for prompt referral. 
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